• Home
  • News

Sichenzia Ross Ference Carmel LLP Represents BioSig Technologies, Inc. in $3 Million Registered Direct Offering

Press Release – New York, NY – May 30, 2024 – Sichenzia Ross Ference Carmel LLP announced today that it represented BioSig Technologies, Inc. (NASDAQ: BSGM), a medical technology company committed to delivering unprecedented accuracy and precision to intracardiac signal visualization, in a $3 million registered direct offering. The Company sold an aggregate of 1,507,683 shares of common stock in a registered direct offering at a purchase price of $1.91 per share, along with a concurrent private placement of warrants to purchase 1,570,683 shares of common stock at an exercise price of $1.78 per share. H.C. Wainwright & Co acted as the sole placement agent for the offering.  

The Sichenzia Ross Ference Carmel LLP team was led by partners Gregory SichenziaBarrett S. DiPaolo, and Avital Perlman, and associates Christian Lichtenberger and Mayank Pradhan